noun a-beta is a term used in the field of neuroscience to refer to amyloid-beta, a protein that plays a key role in the development of Alzheimer's disease.
A-beta levels in cerebrospinal fluid are used as a biomarker for Alzheimer's disease.
Mutations in genes associated with A-beta production can increase the risk of developing Alzheimer's disease.
A-beta is a peptide that plays a crucial role in the pathogenesis of Alzheimer's disease, forming amyloid plaques in the brain.
Research is ongoing to develop drugs targeting A-beta to treat Alzheimer's disease.
A-beta aggregation and toxicity are studied in relation to neurodegenerative diseases.
In the field of literature, 'a-beta' may be used to refer to a type of character or plot device.
Psychologists may use 'a-beta' as a term in the study of cognitive function and memory.
Neuroscientists may use 'a-beta' to refer to a specific protein linked to Alzheimer's disease.
Medical researchers may study 'a-beta' as a potential target for drug development in treating Alzheimer's.
Pharmacists may be involved in dispensing medications that target 'a-beta' in Alzheimer's patients.
Biomedical engineers may work on developing technologies to detect and monitor 'a-beta' levels in the brain.
Neurologists may study the role of 'a-beta' in neurodegenerative diseases like Alzheimer's.
Biochemists may research the biochemical pathways involving 'a-beta' in Alzheimer's disease.
Geriatricians may focus on diagnosing and treating conditions like Alzheimer's that involve 'a-beta'.
Clinical trials coordinators may oversee studies testing new treatments targeting 'a-beta' in Alzheimer's patients.